The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines
- PMID: 10483959
- DOI: 10.1016/s0735-1097(99)00260-0
The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines
Abstract
Objectives: This study was undertaken to project the population-wide effect of full implementation of the Adult Treatment Panel (ATP) II guidelines of the National Cholesterol Education Program (NCEP).
Background: The ATP II has proposed guidelines for cholesterol reduction, but the long-term epidemiologic influence of its components has not been fully examined.
Methods: We used a calibrated, validated simulation of the U.S. population, aged 35 to 84 years to estimate the potential for the NCEP guidelines, under varying assumptions, to reduce coronary heart disease morbidity and mortality and overall mortality from the years 2000 to 2020.
Results: Primary prevention would yield only about half of the benefits of secondary prevention despite requiring nearly twice as many person-years of treatment. The projected increase in quality-adjusted years of life per year of treatment for secondary prevention was 3- to 12-fold higher than for primary prevention. To yield population-wide epidemiologic benefits equivalent to NCEP recommendations for secondary prevention, primary prevention would require a nearly sixfold increase in the number of persons treated compared with NCEP recommendations. All benefits of universal success of the NCEP primary prevention "screen and treat" guidelines could be achieved by a 11 mg/dl (8%) population-wide reduction in low-density lipoprotein cholesterol levels among persons without preexisting coronary heart disease.
Conclusions: The NCEP guidelines for targeted primary prevention can be a useful component of a rational public health strategy, but only as a complement to the more appealing strategies of secondary prevention and "across-the-board" programs to lower all cholesterol levels.
Similar articles
-
Impact of the new National Cholesterol Education Program (NCEP) guidelines on patient management.J Am Acad Nurse Pract. 2003 Aug;15(8):350-60. doi: 10.1111/j.1745-7599.2003.tb00408.x. J Am Acad Nurse Pract. 2003. PMID: 14509100 Review.
-
An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.JAMA. 1999 Dec 1;282(21):2051-7. doi: 10.1001/jama.282.21.2051. JAMA. 1999. PMID: 10591388 Review.
-
New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population.Circulation. 2002 Jan 15;105(2):152-6. doi: 10.1161/hc0202.101971. Circulation. 2002. PMID: 11790693
-
The National Cholesterol Education Program: guidelines, status, and issues.Am J Med. 1991 Feb 21;90(2A):32S-35S. doi: 10.1016/0002-9343(91)90034-u. Am J Med. 1991. PMID: 1994713
-
Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics.Ann Intern Med. 2000 May 16;132(10):769-79. doi: 10.7326/0003-4819-132-10-200005160-00002. Ann Intern Med. 2000. PMID: 10819699
Cited by
-
Are investments in disease prevention complements? The case of statins and health behaviors.J Health Econ. 2014 Jul;36:151-63. doi: 10.1016/j.jhealeco.2014.04.006. Epub 2014 Apr 16. J Health Econ. 2014. PMID: 24814322 Free PMC article.
-
Epidemiological theory, decision theory and mental health services research.Soc Psychiatry Psychiatr Epidemiol. 2004 Nov;39(11):893-8. doi: 10.1007/s00127-004-0872-z. Soc Psychiatry Psychiatr Epidemiol. 2004. PMID: 15549241
-
Preventing cardiovascular disease among Canadians: is the treatment of hypertension or dyslipidemia cost-effective?Can J Cardiol. 2008 Dec;24(12):891-8. doi: 10.1016/s0828-282x(08)70695-0. Can J Cardiol. 2008. PMID: 19052668 Free PMC article.
-
Perceptions of quality-of-life effects of treatments for diabetes mellitus in vulnerable and nonvulnerable older patients.J Am Geriatr Soc. 2008 Jul;56(7):1183-90. doi: 10.1111/j.1532-5415.2008.01757.x. Epub 2008 May 19. J Am Geriatr Soc. 2008. PMID: 18492034 Free PMC article.
-
National trends in statin use by coronary heart disease risk category.PLoS Med. 2005 May;2(5):e123. doi: 10.1371/journal.pmed.0020123. Epub 2005 May 31. PLoS Med. 2005. PMID: 15916463 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical